- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x COA: COENZYME A(Non-covalent)
- 6 x 7LF: 1-(4-fluorophenyl)-2-[2-(4-methylphenyl)-2-oxoethyl]pyrrolo[1,2-a]pyrazin-2-ium(Non-covalent)
7LF.2: 14 residues within 4Å:- Chain A: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422
- Ligands: COA.1
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.33, A:A.53, A:W.56, A:R.57, A:L.83
- pi-Stacking: A:F.44, A:F.104
7LF.6: 14 residues within 4Å:- Chain B: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422
- Ligands: COA.5
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.33, B:A.53, B:W.56, B:R.57, B:L.83
- pi-Stacking: B:F.44, B:F.104
7LF.10: 14 residues within 4Å:- Chain C: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422
- Ligands: COA.9
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:W.33, C:A.53, C:W.56, C:R.57, C:L.83
- pi-Stacking: C:F.44, C:F.104
7LF.14: 14 residues within 4Å:- Chain D: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422
- Ligands: COA.13
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:W.33, D:A.53, D:W.56, D:R.57, D:L.83
- pi-Stacking: D:F.44, D:F.104
7LF.18: 14 residues within 4Å:- Chain E: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422
- Ligands: COA.17
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:W.33, E:A.53, E:W.56, E:R.57, E:L.83
- pi-Stacking: E:F.44, E:F.104
7LF.22: 14 residues within 4Å:- Chain F: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422
- Ligands: COA.21
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:W.33, F:A.53, F:W.56, F:R.57, F:L.83
- pi-Stacking: F:F.44, F:F.104
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 6 residues within 4Å:- Chain A: R.262, I.288, T.289, H.290, Q.417, T.418
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:R.262, A:T.289, A:T.289, A:T.418, A:T.418, A:T.418
GOL.7: 6 residues within 4Å:- Chain B: R.262, I.288, T.289, H.290, Q.417, T.418
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:R.262, B:T.289, B:T.289, B:T.418, B:T.418, B:T.418
GOL.11: 6 residues within 4Å:- Chain C: R.262, I.288, T.289, H.290, Q.417, T.418
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:R.262, C:T.289, C:T.289, C:T.418, C:T.418, C:T.418
GOL.15: 6 residues within 4Å:- Chain D: R.262, I.288, T.289, H.290, Q.417, T.418
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:R.262, D:T.289, D:T.418, D:T.418
GOL.19: 6 residues within 4Å:- Chain E: R.262, I.288, T.289, H.290, Q.417, T.418
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:R.262, E:T.289, E:T.418, E:T.418
GOL.23: 6 residues within 4Å:- Chain F: R.262, I.288, T.289, H.290, Q.417, T.418
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:R.262, F:T.289, F:T.418, F:T.418
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.4: 7 residues within 4Å:- Chain A: R.88, L.89, T.90, V.96, R.203, G.209, L.211
Ligand excluded by PLIPCL.8: 7 residues within 4Å:- Chain B: R.88, L.89, T.90, V.96, R.203, G.209, L.211
Ligand excluded by PLIPCL.12: 7 residues within 4Å:- Chain C: R.88, L.89, T.90, V.96, R.203, G.209, L.211
Ligand excluded by PLIPCL.16: 7 residues within 4Å:- Chain D: R.88, L.89, T.90, V.96, R.203, G.209, L.211
Ligand excluded by PLIPCL.20: 7 residues within 4Å:- Chain E: R.88, L.89, T.90, V.96, R.203, G.209, L.211
Ligand excluded by PLIPCL.24: 7 residues within 4Å:- Chain F: R.88, L.89, T.90, V.96, R.203, G.209, L.211
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garzan, A. et al., Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors. ACS Infect Dis (2017)
- Release Date
- 2017-03-01
- Peptides
- Enhanced intracellular survival protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x COA: COENZYME A(Non-covalent)
- 6 x 7LF: 1-(4-fluorophenyl)-2-[2-(4-methylphenyl)-2-oxoethyl]pyrrolo[1,2-a]pyrazin-2-ium(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garzan, A. et al., Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors. ACS Infect Dis (2017)
- Release Date
- 2017-03-01
- Peptides
- Enhanced intracellular survival protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A